Keywords: Dey Pharma, Merck KGaA, Mylan, USA, Justice Dept, Inflated payments, Whislteblower

Mylan subsidiary Dey Pharma settles $280 million with US DoJ, but Merck KGaA to pay

Article | 22 December 2010

Print This

Dey Pharma, a subsidiary of US generic drugs maker Mylan (Nasdaq: MYL) says that it has settled a law suit ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in